|
B3GNT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63424829224823E-12 |
| Normal-vs-Stage2 |
3.60219998274403E-09 |
| Normal-vs-Stage3 |
5.65600011270817E-10 |
| Normal-vs-Stage4 |
4.01669808525185E-11 |
| Stage1-vs-Stage2 |
7.950800E-01 |
| Stage1-vs-Stage3 |
8.475400E-01 |
| Stage1-vs-Stage4 |
7.960200E-02 |
| Stage2-vs-Stage3 |
9.304800E-01 |
| Stage2-vs-Stage4 |
3.416400E-02 |
| Stage3-vs-Stage4 |
4.782300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
9.37130373301898E-11 |
| Normal-vs-Asian |
4.99610000004314E-06 |
| Caucasian-vs-AfricanAmerican |
1.960560E-01 |
| Caucasian-vs-Asian |
8.363200E-01 |
| AfricanAmerican-vs-Asian |
5.355600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.00290006802106E-10 |
| Male-vs-Female |
4.484600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.4969000483589E-09 |
| Normal-vs-Extreme_Weight |
1.62470037423645E-12 |
| Normal-vs-Obese |
1.12354570092066E-13 |
| Normal-vs-Extreme_Obese |
2.38849999999458E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.755000E-01 |
| Normal_Weight-vs-Obese |
9.087200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.049200E-01 |
| Extreme_Weight-vs-Obese |
2.714000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.475400E-01 |
| Obese-vs-Extreme_Obese |
5.422200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.74740000141927E-08 |
| Normal-vs-Age(41-60Yrs) |
2.03170813506404E-14 |
| Normal-vs-Age(61-80Yrs) |
1.33226762955019E-15 |
| Normal-vs-Age(81-100Yrs) |
3.37039995912392E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.721000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.939400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.146200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.609160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.933000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.426400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
2.38797870366625E-12 |
| Normal-VS-KIRP CIMP |
2.51970000419988E-09 |
| Normal-VS-Unclassified PRCC |
2.72100000309194E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.910200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.274400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.615200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.662360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.652200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.155900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33226762955019E-15 |
| Normal-vs-N1 |
7.45203898588898E-12 |
| Normal-vs-N2 |
1.62129999999872E-05 |
| N0-vs-N1 |
6.896000E-01 |
| N0-vs-N2 |
5.954600E-01 |
| N1-vs-N2 |
7.605000E-01 |
|
|
